VENUS REMEDIES LIMITED (VENUSREM) financials — quarterly results, P&L, cash flow, balance sheet, shareholding

Incorporated in 1989, Venus RemediesLtd is a research-based pharmaceutical company focused on complex injectable formulations across critical care, oncology, anti-infectives and specialty therapies. It operates across 100+ countries, with a product basket of 195+, 1,100+ marketing authorisations an…

VENUSREMUpdated 31 Aug 2026, 20:46

Venus Remedies Limited

Market Cap

₹2,226Cr.

Current Price

₹1,664

High / Low

₹2,044/424

Stock P/E

19.7

ROE15.5%
ROCE20.2%
Book Value₹516
Face Value₹10.0
Dividend Yield0.60%

About

Incorporated in 1989, Venus RemediesLtd is a research-based pharmaceutical company focused on complex injectable formulations across critical care, oncology, anti-infectives and specialty therapies. It operates across 100+ countries, with a product basket of 195+, 1,100+ marketing authorisations and 700+ dossiersfiled.{# {# https://www.bseindia.com/xml-data/corpfiling/AttachHis/29971821-bfab-4659-a9d8-7cf5dc170d02.pdf#page=36 #} #}

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios
CategoryMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days495041453834121958575755
Inventory Days18921023024228328213012112312298122
Days Payable3536504867707448535467104
Cash Conversion Cycle20322322023925424667931291268873
Working Capital Days54735223-377688411812997104
ROCE %6%5%1%2%1%3%6%10%8%9%12%20%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 31 August 2026 at 20:46


Designed & Shipped by Harshit Bansal